VA-DATAXSTREAM
23.4.2024 15:08:30 CEST | Business Wire | Press release
DataXstream LLC, an SAP solution provider focused on order management and point of sale for sales and distribution, today announced it is expanding into the Nordic region after a successful implementation of its OMS+ platform across two key business units for the Martin & Servera group, Sweden’s leading restaurant and catering distributor that specializes in the needs of the restaurant industry.
Learn more about DataXstream OMS+ here.
Martin & Servera is a group of companies based in Stockholm who was faced with the challenge of managing multiple ERP systems that were facing end of life, so they decided to consolidate onto a single instance of SAP S/4 HANA for all their business units. As part of this migration, Martin & Servera turned to DataXstream’s OMS+ cross-channel order management platform to help them enable faster order entry and streamline their sales and order processes between all companies within their organization.
Working with DataXstream’s LATAM delivery team, Kötthallen Sorunda, Sweden's leading wholesaler of meat, game, poultry and charcuterie and Fiskhallen Sorunda, the leading sustainable seafood wholesaler in Sweden, were the first two business units to successfully deploy OMS+ across their live networks. The go-live transition went exceptionally smooth, with over 500 orders created on the first day to meet the demand for the next three days.
“The complex nature of Martin & Servera’s sales and order management environment is exactly what OMS+ is built for. They are processing over 15,000 sales order lines a month and can now streamline and automate those processes in a fraction of the time, resulting in faster order entry and a better customer experience. This go-live stands out as one of the best I have ever been part of, thanks to the excellent integration, support and collaboration between Martin & Servera, the systems integrator, DataXstream and the Steering Committee,” said Diego Perelman, President, DataXstream LATAM. “Our move into the Nordic region highlights the continued need among B2B organizations to reduce complexity and streamline sales order processes within SAP SD environments.”
The OMS+ Difference
The ease of deployment across Martin & Servera’s newly installed S/4 HANA backbone is another hallmark of OMS+ as the only platform on the market today that is directly embedded into SAP as a single interface. This allows Martin & Servera to seamlessly align all their companies’ ERPs and applications onto a single platform, reducing complexity and customization, while giving them access to the same real-time master data from SAP and supporting their unique business needs.
As a result, OMS+ will equip Martin & Servera’s sales associates with:
- Real-time visibility into customer history, discounts, and product availability
- Faster manual order entry capabilities
- Access to real-time material characteristics to swiftly find the right materials for customers
- Full sales communications and tracking
Additionally, as OMS+ is embedded into SAP, it aligns perfectly with their roadmap, ensuring that new SAP functionalities are automatically available in OMS+ and the flexibility of its interface will allow Martin & Servera to adjust it easily to their unique requirements.
“We had several challenges associated with this project including an ongoing S/4 implementation that was going on in parallel to the OMS+ deployment,” said Thomas Tolvanen, IT Manager, Grönsakshallen Sorunda AB. “We are incredibly impressed by DataXstream and their professional delivery team. They have been instrumental in the S/4 process design to streamline our processes and complexity. Likewise, their deep knowledge and expertise to identify bugs and errors in customization and master data has been invaluable to us during this process. DataXstream is one of our most valuable partners.”
For additional information, please visit www.dataxstream.com or find us on the SAP store at https://store.sap.com/dcp/en/product/display-0000006561_live_v1
About Martin & Servera
The Martin & Servera group offers goods, services and knowledge for restaurants and commercial kitchens in Sweden. We are a Swedish, family-owned group. Responsible and long-term business is an important part of our business. The Martin & Servera group consists of Martin & Servera Restauranghandel, Martin & Servera Logistics, Martin & Servera Restaurant Shops, Galatea, the Vegetable Hall Sorunda, the Fish Hall Sorunda and the Meat Hall Sorunda.
About DataXstream
DataXstream is an SAP® Gold and Endorsed App Partner dedicated to building solutions on emerging technologies that maximize the ROI of our customers’ SAP® infrastructure. As members of the SAP® marketplace, DataXstream’s products can be found in the SAP® Store. Your company is already running the most powerful ERP solution; empower your employees with DataXstream’s OMS+ to take your organization’s sale and customer buying experience to new levels.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240423069303/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom